| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 5 Sep 2025 | 29 Aug 2025 |
| Vaxfab Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2025 inter alia to consider and approve Pursuant to Regulation 29(1) of the SEBI Listing Regulations we wish to inform you that next Meeting of the Board of Directors (the Board) of the Company will be held on Friday 5th September 2025 to consider inter alia proposal for Increase in Authorised capital and raising of funds by way of preferential issue subject to such regulatory/statutory approvals as may be required including approval of the shareholders of the Company. | ||
| Board Meeting | 29 Aug 2025 | 25 Aug 2025 |
| Vaxfab Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/08/2025 inter alia to consider and approve Pursuant to Regulation 29(1) of the SEBI Listing Regulations we wish to inform you that a Meeting of the Board of Directors (the Board) of the Company will be held on Friday 29th August 2025 to consider inter alia proposal for Increase in Authorised capital and raising of funds through any or all of various methods including by way of preferential issue subject to such regulatory/statutory approvals as may be required including approval of the shareholders of the Company. The Board of Directors (the Board) at its meeting held on 29th August, 2025 which commenced at 05:30 p.m. and concluded at 06:00 p.m., have inter alia, transacted and approved the following businesses: 1. Deferred the matter regarding Increase in authorized Share Capital of the Company for next Board Meeting of the Company. 2. Decided and approved to raise funds by way of preferential issue mode. (As Per BSE Announcement Dated on:29.08.2025) | ||
| Board Meeting | 14 Aug 2025 | 11 Aug 2025 |
| Vaxfab Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 inter alia to consider and approve Dear Sir/ Madam NOTICE IS HEREBY given that a Meeting of the Board of Directors of Vaxfab Enterprises Limited (the Company) is scheduled to be held on Thursday August 14 2025 to inter alia consider and approve the unaudited financial results of the Company for the quarter ended June 30 2025. We have vide our submission dated June 30 2025 informed that the trading window for dealing in the securities of the Company by all Designated Persons has been closed from July 01 2025 and will continue to remain closed till 48 hours after the submission of the financial results for the quarter ended on June 30 2025. | ||
| Board Meeting | 27 May 2025 | 22 May 2025 |
| Vaxfab Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2025 inter alia to consider and approve Intimation of the Board Meeting to be held on Tuesday 27th May 2025. Outcome of Board Meeting held on Tuesday, 27th May, 2025. (As Per BSE Announcement Dated on :27.05.2025) | ||
| Board Meeting | 13 Feb 2025 | 10 Feb 2025 |
| Vaxfab Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 inter alia to consider and approve 1. To consider and approve the Un-Audited Financial Results of the Company for the quarter and nine months ended as on 31st December 2024 along with Limited Review Report thereon. 2. To transact other businesses as per agenda being circulated. Outcome of the Board Meeting held today i.e., Thursday, 13th February, 2025 (As per BSE Announcement Dated on 13/02/2025) | ||
| Board Meeting | 2 Dec 2024 | 2 Dec 2024 |
| Outcome of Board Meeting and Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | ||
| Board Meeting | 14 Nov 2024 | 29 Oct 2024 |
| Quarterly Results The Board Meeting to be held on 12/11/2024 has been revised to 14/11/2024 The Board Meeting to be held on 12/11/2024 has been revised to 14/11/2024 (As Per NSE Announcement Dated on: 11/11/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.